Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology.
Virax Biolabs Group stock last closed at $0.59, down 2.8% from the previous day, and has decreased 76.59% in one year. It has underperformed other stocks in the Biotechnology industry by 0.47 percentage points. Virax Biolabs Group stock is currently +13.46% from its 52-week low of $0.52, and -81.56% from its 52-week high of $3.20.
There are currently 4.34M VRAX shares outstanding. The market capitalization of VRAX is $2.56M. In the past 24 hours, 60,600 VRAX shares were traded.
You will need a brokerage account in order to access the NASDAQ market and buy VRAX stock.
Based on our research, eToro is the best online stock brokerage. Here's why:
Get $10 towards your share purchase by signing up for an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen your brokerage, the next step is to fill out some personal info so you are able to invest in VRAX stock today.
Now that you have created your account on the best stock app for beginners, your next step is to transfer the money for your investment:
Check out this video walkthrough if you need help depositing funds into your investment account.
After you have chosen the best place to buy Virax Biolabs Group stock, it's important to research their stock before you buy, so you can wrap your head around the risk as well as the opportunity.
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis.
You can see all of the due diligence checks on VRAX's stock page.
You can use many financial metrics, analyses, models, and charts to gauge VRAX's fair value.
Using relative valuations ratios:
You can do additional valuation research on VRAX's stock here.
You can dive deeper into what analysts are saying on the Virax Biolabs Group stock forecast page.
Last year, VRAX revenue was $6.33k. In the past 5 year, VRAX's revenue has increased by -42.4% per year. This was slower than the Biotechnology industry average of 67.91%.
Learn more about VRAX's earnings and revenue performance here.
Over the last 12 months, insiders at VRAX have not bought or sold any shares.
Dig into more about who owns VRAX shares here.
No, Virax Biolabs Group doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two primary types of orders:
Press the Open button and your broker will place the order.
If you require more help with investing in stocks on eToro, click the helpful video below:
Now that you own some VRAX stock, you'll want to stay up-to-date on your investment.
Start a watchlist to get alerted to the latest events about your VRAX stock.
To reiterate, here are the 6 steps you need to take to buy Virax Biolabs Group stock right now:
If you are looking for a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Virax Biolabs Group, add VRAX to your watchlist below.